Patent Assignment
Reel/Frame 024879/0568
Assignment of Assignor's Interest
Recorded: 2010-08-25
Pages: 12
Assignor
DYNOGEN PHARMACEUTICALS, INC.
Executed: 2010-08-17
Assignee
EDUSA PHARMACEUTICALS, INC.
104 CARNEGIE CENTER, SUITE 214, PRINCETON, NEW JERSEY, 08540
Covered Properties
(33)
Use of 4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)Thieno(2,3-D)-Pyrimidine for Treating of Urinary Incontinence
4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)Thieno[2,3-D)Pyrimidine in the Treatment of Functional Bowel Disorder
New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidine
Application:
10/525,532 →
Publication:
US 2006/0167005
New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
Application:
10/617,847 →
Publication:
US 2004/0048874
Method of treating functional bowel disorders
Application:
10/757,364 →
Publication:
US 2004/0147509
Method of Treating Nausea, Vomiting, Retching or Any Combination Thereof
Application:
10/757,981 →
Publication:
US 2004/0147510
Methods for Treating Lower Urinary Tract Disorders and the Related Disorders Vulvodynia and Vulvar Vestibulitis Using CAV2.2 Subunit Calcium Channel Modulators
Method of Treating Lower Urinary Tract Disorders
Method of Treating Nausea, Vomiting, Retching or Any Combination Thereof
Method of Treating Lower Urinary Tract Disorders
Methods of Treating Non-Inflammatory Gastrointestinal Tract Disorders Using CAV2.2 Subunit Calcium Channel Modulators
Compositions useful for treating gastrointestinal motility disorders
Application:
10/928,624 →
Publication:
US 2005/0059704
Thiazolidinone, Oxazolidinone, and Imidazolone Derivatives for Treating Lower Urinary Tract and Related Disorders
Methods of Treating Gastrointestinal Tract Disorders Using Sodium Channel Modulators
Methods of decreasing intestinal motility
Application:
11/119,357 →
Publication:
US 2005/0192270
Dual acting SNRI-NMDA antagonists for the treatment of genitourinary disorders
Application:
11/145,022 →
Publication:
US 2005/0282859
Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
Application:
11/389,887 →
Publication:
US 2006/0293309
Compositions useful for increasing lower esophageal sphincter pressure
Application:
11/413,857 →
Publication:
US 2006/0189648
Method of treating functional bowel disorders
Application:
11/441,905 →
Publication:
US 2006/0217391
Methods of Using Ziconotide to Treat Overactive Bladder
Compositions and methods for treating gastrointestinal hypomotility and associated disorders
Application:
11/479,139 →
Publication:
US 2007/0010543
Method for Treatment of Gastroesophageal Reflux Disease
Application:
11/507,010 →
Publication:
US 2006/0281781
Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators
Application:
11/598,393 →
Publication:
US 2007/0060652
Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidine
Application:
11/728,947 →
Publication:
US 2007/0254891
Soluble salts of thieno[2,3-d]pyrimidine derivatives
Application:
11/728,966 →
Publication:
US 2007/0254899
Compositions Useful for Treating Irritable Bowel Syndrome
Application:
12/069,439 →
Publication:
US 2008/0269276
Compositions useful for treating gastroesophageal reflux disease
Application:
12/156,787 →
Publication:
US 2009/0131471
New Therapeutic Use of 4-(2-Fluorophenyl)-6-Methyl-2-(1-Piperazinyl)Thieno[2,3-D]Pyrimidine
Application:
12/200,102 →
Publication:
US 2009/0215791
Preventive and Therapeutic medicament for gastroesophageal reflux disease
Application:
12/219,806 →
Publication:
US 2008/0293762
Compositions useful for treating gastrointestinal motility disorders
Application:
12/288,390 →
Publication:
US 2009/0048287
Methods of Treating Non-Painful Bladder Disorders Using ALPHA2DELTA Subunit Calcium Channel Modulators
Application:
12/425,674 →
Publication:
US 2009/0203792
Compositions Useful For Treating Irritable Bowel Syndrome
Application:
12/635,498 →
Publication:
US 2010/0152231
Compositions Useful for Treating Gastroesophageal Reflux Disease
Application:
12/752,702 →
Publication:
US 2010/0247584
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 30, 2003
From: BARDSLEY, HAZEL JUDITH; CAVALLA, DAVID; GRISTWOOD, ROBERT WILLIAM
To: ARACHNOVA THERAPEUTICS LTD.
Reel/Frame 014642/0922 →
Assignment of Assignor's Interest
Jan 30, 2004
From: LANDAU, STEVEN B.
To: DYNOGEN PHARMACEUTICALS INC.
Reel/Frame 014928/0489 →
Assignment of Assignor's Interest
Feb 6, 2004
From: LANDAU, STEVEN B.; MILLER, CHERYL L.; THOR, KARL B.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 014952/0095 →
Assignment of Assignor's Interest
Apr 2, 2004
From: FRASER, MATTHEW OLIVER; THOR, KARL BRUCE; BURGARD, EDWARD C.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 015164/0933 →
Assignment of Assignor's Interest
May 3, 2004
From: LANDAU, STEVEN B.; MILLER, CHERYL L.; FRASER, MATTHEW O.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 015281/0391 →
Assignment of Assignor's Interest
Oct 1, 2004
From: CAVALLA, DAVID; GRISTWOOD, ROBERT WILLIAM
To: ARACHNOVA LTD.
Reel/Frame 015210/0668 →
Assignment of Assignor's Interest
Oct 6, 2004
From: FRASER, MATTHEW OLIVER; LANDAU, STEVEN B.; BURGARD, EDWARD C.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 015222/0657 →
Assignment of Assignor's Interest
Oct 13, 2004
From: LANDAU, STEVEN B.; ASHBURN, THEODORE T.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 015880/0110 →
Assignment of Assignor's Interest
Jan 31, 2005
From: CAVALLA, DAVID; GRISTWOOD, ROBERT WILLIAM
To: ARACHNOVA LTD.
Reel/Frame 015635/0169 →
Assignment of Assignor's Interest
Apr 28, 2005
From: FRASER, MATTHEW OLIVER; THOR, KARL BRUCE; BURGARD, EDWARD C.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 016174/0450 →
Assignment of Assignor's Interest
May 27, 2005
From: CAVALLA, DAVID; GRISTWOOD, ROBERT WILLIAM
To: ARACHNOVA LTD.
Reel/Frame 016284/0959 →
Assignment of Assignor's Interest
Jul 13, 2005
From: ARACHNOVA LTD.
To: ARACHNOVA THERAPEUTICS LTD.
Reel/Frame 016517/0269 →
Assignment of Assignor's Interest
Jul 13, 2005
From: ARACHNOVA LTD.
To: ARACHNOVA THERAPEUTICS LTD.
Reel/Frame 016517/0211 →
Assignment of Assignor's Interest
Sep 6, 2005
From: THOR, KARL BRUCE
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 016736/0364 →
Corrective Assignment to Correct the Assignee, Previously Recorded at Reel 016284 Frame 0959.
Oct 11, 2005
From: CAVALLA, DAVID; GRISTWOOD, ROBERT WILLIAM
To: ARACHNOVA THERAPEUTICS LTD.
Reel/Frame 016873/0433 →
Assignment of Assignor's Interest
Sep 1, 2006
From: THOR, KARL BRUCE; RICCA, DANIEL J.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 018227/0718 →
Assignment of Assignor's Interest
Oct 24, 2007
From: LANDAU, STEVEN B.; MILLER, CHERYL L.; FRASER, MATTHEW O.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 020004/0355 →
Assignment of Assignor's Interest
Oct 24, 2007
From: LANDAU, STEVEN B.; MILLER, CHERYL L.; THOR, KARL B.
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 020004/0345 →
Security Agreement
Jan 3, 2008
From: DYNOGEN PHARMACEUTICALS, INC.
To: ARACHNOVA THERAPEUTICS LIMITED
Reel/Frame 020309/0537 →
Assignment of Assignor's Interest
Jan 24, 2008
From: ARACHNOVA THERAPEUTICS LIMITED
To: DYNOGEN PHARMACEUTICALS, INC.
Reel/Frame 020409/0077 →
Assignment of Assignor's Interest
Apr 6, 2010
From: DYNOGEN PHARMACEUTICALS, INC.
To: DRUG ASSETS ACQUISITION, INC.
Reel/Frame 024192/0324 →
Change of Name
Apr 6, 2010
From: DRUG ASSETS ACQUSITION, INC.
To: EDUSA PHARMACEUTICALS, INC.
Reel/Frame 024192/0924 →